Skip to main content
. 2019 Nov 6;19:201. doi: 10.1186/s12871-019-0875-7

Fig. 2.

Fig. 2

A cumulative cost analysis of all blood component products in the subgroup of patients with “long” CPB-times revealed cost savings of 619.8 € per patient treated in the “point-of-care” 4-chamber ROTEM®. Costs savings were not annihilated by the additional costs for ROTEM® testing (on average: 68.3 € per patient)